Editas Medicine, Inc.
US ˙ NasdaqGS ˙ US28106W1036

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Akshay Vaishnaw. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Akshay Vaishnaw telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:SRRK / Scholar Rock Holding Corporation President of R&D, Director 616,205
US:ALNY / Alnylam Pharmaceuticals, Inc. President 22,774
US:EDIT / Editas Medicine, Inc. Director 11,538
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Akshay Vaishnaw. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam EDIT / Editas Medicine, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di EDIT / Editas Medicine, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

EDIT / Editas Medicine, Inc. Insider Trades
Penjualan Orang Dalam EDIT / Editas Medicine, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di EDIT / Editas Medicine, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

EDIT / Editas Medicine, Inc. Insider Trades
Pembelian Orang Dalam SRRK / Scholar Rock Holding Corporation - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di EDIT / Editas Medicine, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

SRRK / Scholar Rock Holding Corporation Insider Trades
Penjualan Orang Dalam SRRK / Scholar Rock Holding Corporation - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di EDIT / Editas Medicine, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

SRRK / Scholar Rock Holding Corporation Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Akshay Vaishnaw sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2025-05-30 2025-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X -1,620 616,205 -0.26 30.01 -48,612 18,490,587
2025-05-30 2025-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X -5,130 617,825 -0.82 29.63 -152,000 18,305,969
2025-04-29 2025-04-27 4 SRRK Scholar Rock Holding Corp
Common Stock
A - Award 500,000 622,955 406.65
2025-04-29 2025-04-27 4 SRRK Scholar Rock Holding Corp
Common Stock
A - Award 100,000 122,955 435.63
2024-07-01 2024-06-27 4 SRRK Scholar Rock Holding Corp
Common Stock
A - Award 13,500 22,955 142.78
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -192 22,774 -0.84 189.31 -36,348 4,311,346
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -17 22,966 -0.07 188.40 -3,203 4,326,794
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -101 22,983 -0.44 187.37 -18,924 4,306,325
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,107 23,084 -4.58 186.39 -206,334 4,302,627
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,869 24,191 -7.17 185.54 -346,774 4,488,398
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -771 26,060 -2.87 184.70 -142,404 4,813,282
2023-08-07 2023-08-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 3,859 26,831 16.80
2023-08-07 2023-08-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5,082 22,972 28.41
2023-04-28 2023-04-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -168 17,890 -0.93 197.08 -33,109 3,525,761
2023-04-28 2023-04-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -104 18,058 -0.57 195.65 -20,348 3,533,048
2023-04-28 2023-04-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,013 18,162 -5.28 194.94 -197,474 3,540,500
2023-04-28 2023-04-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -910 19,175 -4.53 193.93 -176,476 3,718,608
2023-04-28 2023-04-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -197 20,085 -0.97 193.18 -38,056 3,880,020
2023-04-28 2023-04-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5,312 20,282 35.48
2023-02-14 2023-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,302 14,970 -22.32 217.05 -933,749 3,249,238
2023-02-14 2023-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -19,447 19,272 -50.23 216.38 -4,207,942 4,170,075
2023-02-14 2023-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -10,279 38,719 -20.98 215.59 -2,216,050 8,347,429
2023-02-14 2023-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,307 48,998 -4.50 214.28 -494,344 10,499,291
2023-02-14 2023-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,709 51,305 -3.22 213.13 -364,239 10,934,635
2023-02-14 2023-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 30,913 53,014 139.87 63.00 1,947,519 3,339,882
2022-12-07 2022-12-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1,324 22,101 -5.65 226.20 -299,489 4,999,246
2022-12-07 2022-12-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,368 23,425 11.25 42.22 99,977 989,004
2022-12-07 2022-12-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1,587 21,057 8.15 63.00 99,981 1,326,591
2022-12-07 2022-12-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1,124 19,470 6.13 88.95 99,980 1,731,856
2022-08-05 2022-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -198 18,346 -1.07 210.75 -41,728 3,866,420
2022-08-05 2022-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -180 18,544 -0.96 210.66 -37,919 3,906,479
2022-08-05 2022-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -195 18,724 -1.03 210.22 -40,993 3,936,159
2022-08-05 2022-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -5,479 18,919 -22.46 189.76 -1,039,695 3,590,069
2022-08-05 2022-08-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 3,859 24,398 18.79
2022-08-05 2022-08-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 4,241 20,539 26.02
2022-08-05 2022-08-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5,083 16,298 45.32
2022-05-27 2022-05-26 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
A - Award 28,000 28,000
2022-02-25 2022-02-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 29,842 29,842
2022-01-04 2021-12-31 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 22,380 22,380
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -303 11,215 -2.63 195.11 -59,118 2,188,159
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -145 11,518 -1.24 193.67 -28,082 2,230,691
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -126 11,663 -1.07 193.37 -24,365 2,255,274
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -73 11,789 -0.62 192.25 -14,034 2,266,435
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,000 11,862 -7.77 191.45 -191,450 2,270,980
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -125 12,862 -0.96 190.86 -23,858 2,454,841
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -142 12,987 -1.08 190.39 -27,035 2,472,595
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -73 13,129 -0.55 190.33 -13,894 2,498,843
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5 13,202 -0.04 190.27 -951 2,511,945
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -144 13,207 -1.08 190.02 -27,363 2,509,594
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -144 13,351 -1.07 189.24 -27,251 2,526,543
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8 13,495 -0.06 189.18 -1,513 2,552,984
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -73 13,503 -0.54 189.01 -13,798 2,552,202
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -127 13,576 -0.93 188.26 -23,909 2,555,818
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -130 13,703 -0.94 187.35 -24,356 2,567,257
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -137 13,833 -0.98 187.08 -25,630 2,587,878
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -124 13,970 -0.88 186.22 -23,091 2,601,493
2021-12-23 2021-12-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -122 14,094 -0.86 186.48 -22,751 2,628,249
2021-12-23 2021-12-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1 14,216 -0.01 190.50 -190 2,708,148
2021-12-23 2021-12-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2,415 14,217 -14.52 189.13 -456,749 2,688,861
2021-12-23 2021-12-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5,417 16,632 48.30
2021-08-11 2021-08-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2013 (right to buy)
M - Exercise X -10,834 10,832 -50.00
2021-08-11 2021-08-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -10,834 11,215 -49.14 200.00 -2,166,800 2,243,000
2021-08-11 2021-08-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 10,834 22,049 96.60 63.00 682,542 1,389,087
2021-06-22 2021-06-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -970 2,368 -29.06
2021-06-22 2021-06-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2013 (right to buy)
M - Exercise X -10,834 21,666 -33.34
2021-06-22 2021-06-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -14,708 11,215 -56.74 175.00 -2,573,900 1,962,625
2021-06-22 2021-06-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 970 25,923 3.89 42.22 40,953 1,094,469
2021-06-22 2021-06-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 10,834 24,953 76.73 63.00 682,542 1,572,039
2021-06-07 2021-06-03 4 EDIT Editas Medicine, Inc.
Stock Option (right to buy)
A - Award 11,538 11,538
2021-06-01 2021-05-27 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
A - Award 7,800 7,800
2021-04-21 2021-04-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -107 14,119 -0.75 138.48 -14,817 1,955,199
2021-04-21 2021-04-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -530 14,226 -3.59 137.60 -72,928 1,957,498
2021-04-21 2021-04-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,892 14,756 -11.36 136.84 -258,901 2,019,211
2021-04-21 2021-04-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -203 16,648 -1.20 135.41 -27,488 2,254,306
2021-04-21 2021-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -85 16,851 -0.50 134.56 -11,438 2,267,528
2021-04-21 2021-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2,266 16,936 -11.80 131.75 -298,546 2,231,318
2021-04-21 2021-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -417 19,202 -2.13 140.02 -58,388 2,688,664
2021-04-21 2021-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -622 19,619 -3.07 138.64 -86,234 2,719,978
2021-04-21 2021-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -989 20,241 -4.66 137.60 -136,086 2,785,162
2021-04-21 2021-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,678 21,230 -7.32 136.76 -229,483 2,903,415
2021-04-21 2021-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5,083 22,908 28.52
2021-02-26 2021-02-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 28,800 28,800
2021-02-16 2021-02-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -92 17,825 -0.51 152.53 -14,033 2,718,847
2021-02-16 2021-02-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1,618 17,917 -8.28 156.00 -252,408 2,795,052
2021-02-16 2021-02-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2017 (right to buy)
A - Award 8,334 25,000 50.01
2021-02-16 2021-02-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5,416 19,535 38.36
2020-10-01 2020-09-29 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -971 3,338 -22.53
2020-10-01 2020-09-29 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -971 14,119 -6.43 140.00 -135,940 1,976,660
2020-10-01 2020-09-29 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 971 15,090 6.88 42.22 40,996 637,100
2020-06-24 2020-06-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -970 4,309 -18.37
2020-06-24 2020-06-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -195 14,119 -1.36 152.97 -29,829 2,159,783
2020-06-24 2020-06-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -334 14,314 -2.28 152.22 -50,841 2,178,877
2020-06-24 2020-06-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -180 14,648 -1.21 150.34 -27,061 2,202,180
2020-06-24 2020-06-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -83 14,828 -0.56 149.09 -12,374 2,210,707
2020-06-24 2020-06-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -178 14,911 -1.18 148.48 -26,429 2,213,985
2020-06-24 2020-06-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 970 15,089 6.87 42.22 40,953 637,058
2020-06-18 2020-06-16 4 SRRK Scholar Rock Holding Corp
Stock Option (right to buy)
A - Award 13,000 13,000
2020-06-12 2020-06-10 4 EDIT Editas Medicine, Inc.
Stock Option (right to buy)
A - Award 11,538 11,538
2020-04-22 2020-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -971 5,279 -15.54
2020-04-22 2020-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
M - Exercise X -21,000 0 -100.00
2020-04-22 2020-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -21,971 14,119 -60.88 140.00 -3,075,940 1,976,660
2020-04-22 2020-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 971 36,090 2.76 42.22 40,996 1,523,720
2020-04-22 2020-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 21,000 35,119 148.74 42.22 886,620 1,482,724
2020-04-09 2020-04-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -98 14,119 -0.69 106.52 -10,439 1,503,956
2020-04-09 2020-04-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2,415 14,217 -14.52 104.75 -252,971 1,489,231
2020-04-09 2020-04-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5,417 16,632 48.30
2020-02-28 2020-02-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 27,623 27,623
2020-02-11 2020-02-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -18,750 6,250 -75.00
2020-02-11 2020-02-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
M - Exercise X -4,000 21,000 -16.00
2020-02-11 2020-02-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -23,708 11,215 -67.89 125.00 -2,963,500 1,401,875
2020-02-11 2020-02-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 4,000 34,923 12.94 42.22 168,880 1,474,449
2020-02-11 2020-02-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 18,750 30,923 154.03 42.22 791,625 1,305,569
2019-12-26 2019-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2017 (right to buy)
A - Award 8,333 16,666 100.00
2019-11-26 2019-11-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2017 (right to buy)
A - Award 8,333 8,333
2019-08-07 2019-08-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6,250 25,000 33.33
2019-08-07 2019-08-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2015 (right to buy)
A - Award 7,500 30,000 33.33
2019-08-07 2019-07-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 48 515 10.28
2019-06-14 2019-06-12 4 EDIT Editas Medicine, Inc.
Stock Option (right to buy)
A - Award 11,538 11,538
2019-06-07 2019-06-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6,250 18,750 50.00
2019-06-07 2019-04-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 51 467 12.26
2019-06-07 2018-10-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 21 416 5.32
2019-05-23 2019-05-21 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
A - Award 20,316 20,316
2019-03-01 2019-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 32,500 32,500
2018-09-28 2018-09-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6,250 12,500 100.00
2018-09-28 2018-09-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2015 (right to buy)
A - Award 7,500 22,500 50.00
2018-08-23 2018-08-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2015 (right to buy)
A - Award 7,500 15,000 100.00
2018-08-14 2018-08-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -766 12,173 -5.92 90.95 -69,668 1,107,134
2018-08-14 2018-08-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 1,724 12,939 15.37
2018-08-14 2018-08-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Based Stock Option 2014 (right to buy)
A - Award 11,707 35,125 49.99
2018-08-14 2018-08-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Based Stock Option 2013 (right to buy)
A - Award 10,832 32,500 49.99
2018-08-14 2018-07-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 29 395 7.92
2018-08-14 2018-04-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 28 366 8.28
2018-06-19 2018-06-15 4 EDIT Editas Medicine, Inc.
Stock Option (right to buy)
A - Award 11,538 11,538
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -44,641 0 -100.00
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -38,913 0 -100.00
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -5,000 0 -100.00
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6,380 11,215 -36.26 145.27 -926,823 1,629,203
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -20,172 17,595 -53.41 144.53 -2,915,459 2,543,005
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -19,213 37,767 -33.72 143.46 -2,756,297 5,418,054
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -21,336 56,980 -27.24 142.57 -3,041,874 8,123,639
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -15,000 78,316 -16.07 141.69 -2,125,350 11,096,594
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6,453 93,316 -6.47 140.45 -906,324 13,106,232
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5,000 99,769 5.28 7.10 35,500 708,360
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 38,913 94,769 69.67 16.43 639,341 1,557,055
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 44,641 55,856 398.05 18.66 833,001 1,042,273
2018-03-05 2018-03-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 25,000 25,000
2017-12-21 2017-12-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Based Stock Option 2016 (right to buy)
A - Award 6,250 6,250
2017-12-21 2017-12-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
G - Gift -320 11,215 -2.77
2017-11-08 2017-11-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2015 (right to buy)
A - Award 7,500 7,500
2017-11-01 2017-10-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -33,666 0 -100.00
2017-11-01 2017-10-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,693 11,535 -24.25 122.79 -453,463 1,416,383
2017-11-01 2017-10-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -17,755 15,228 -53.83 121.69 -2,160,606 1,853,095
2017-11-01 2017-10-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -11,418 32,983 -25.72 120.78 -1,379,066 3,983,687
2017-11-01 2017-10-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -800 44,401 -1.77 119.79 -95,832 5,318,796
2017-11-01 2017-10-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 33,666 45,201 291.86 21.35 718,769 965,041
2017-09-22 2017-09-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2013 (right to buy)
A - Award 10,834 10,834
2017-07-11 2017-07-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2014 (right to buy)
A - Award 11,709 23,418 100.00
2017-06-19 2017-06-15 4 EDIT Editas Medicine, Inc.
Stock Option (right to buy)
A - Award 11,538 11,538
2017-06-15 2017-06-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -328 33,666 -0.96
2017-06-15 2017-06-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -1,340 44,641 -2.91
2017-06-15 2017-06-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -430 11,535 -3.59 74.31 -31,953 857,166
2017-06-15 2017-06-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1,340 11,965 12.61 18.66 25,004 223,267
2017-06-15 2017-06-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 328 10,625 3.19 21.35 7,003 226,844
2017-05-25 2017-05-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -11,000 33,994 -24.45
2017-05-25 2017-05-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -11,000 10,297 -51.65 75.00 -825,000 772,275
2017-05-25 2017-05-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 11,000 21,297 106.83 21.35 234,850 454,691
2017-05-17 2017-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -32,750 0 -100.00
2017-05-17 2017-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -11,000 44,994 -19.64
2017-05-17 2017-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -11,000 10,297 -51.65 65.00 -715,000 669,305
2017-05-17 2017-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 11,000 21,297 106.83 21.35 234,850 454,691
2017-05-17 2017-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -32,750 10,297 -76.08 65.00 -2,128,750 669,305
2017-05-17 2017-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 32,750 43,047 318.05 31.39 1,028,022 1,351,245
2017-01-04 2016-12-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -4,356 55,994 -7.22
2017-01-04 2016-12-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -4,019 45,981 -8.04
2017-01-04 2016-12-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -1,172 38,913 -2.92
2017-01-04 2016-12-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -5,000 10,297 -32.69 37.44 -187,200 385,520
2017-01-04 2016-12-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4,356 15,297 39.81 21.35 93,001 326,591
2017-01-04 2016-12-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4,019 10,941 58.06 18.66 74,995 204,159
2017-01-04 2016-12-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1,172 6,922 20.38 16.43 19,256 113,728
2016-12-22 2016-12-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 25,000 25,000
2016-12-02 2016-11-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -29,165 0 -100.00
2016-12-02 2016-11-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,500 5,750 -20.69 46.14 -69,208 265,298
2016-12-02 2016-11-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -13,297 7,250 -64.72 45.55 -605,662 330,229
2016-12-02 2016-11-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -14,368 20,547 -41.15 44.34 -637,127 911,126
2016-12-02 2016-11-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 29,165 34,915 507.22 22.75 663,504 794,316
2016-07-29 2016-07-28 4 EDIT Editas Medicine, Inc.
Stock Option (right to buy)
A - Award 23,076 23,076
2016-07-29 3 EDIT Editas Medicine, Inc.
No securities are beneficially owned
0
2016-02-25 2016-02-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 10,000 10,000
2016-02-03 2016-02-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2014 (right to buy)
A - Award 11,709 11,709
2015-12-22 2015-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 30,000 30,000
2015-11-30 2015-11-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -835 29,165 -2.78
2015-11-30 2015-11-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -4,915 40,085 -10.92
2015-11-30 2015-11-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4,915 5,750 588.62 16.43 80,753 94,472
2015-11-30 2015-11-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 835 835 22.75 18,996 18,996
2015-06-18 2015-06-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -6,250 0 -100.00
2015-06-18 2015-06-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -2,500 5,000 -33.33
2015-06-18 2015-06-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -350 0 -100.00 131.00 -45,850
2015-06-18 2015-06-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,800 350 -83.72 130.06 -234,100 45,519
2015-06-18 2015-06-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,667 2,150 -55.37 128.79 -343,479 276,895
2015-06-18 2015-06-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,933 4,817 -44.95 128.10 -503,811 617,050
2015-06-18 2015-06-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2,500 8,750 40.00 7.10 17,750 62,125
2015-06-18 2015-06-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6,250 6,250 9.30 58,125 58,125
2015-05-05 2015-05-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 35,125 35,125
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -6,250 6,250 -50.00
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -2,500 7,500 -25.00
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -644 0 -100.00 119.38 -76,881
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,000 644 -60.83 118.16 -118,160 76,095
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,080 1,644 -55.85 117.35 -244,088 192,923
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,802 3,724 -50.52 116.34 -442,325 433,250
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,224 7,526 -13.99 115.29 -141,115 867,673
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2,500 8,750 40.00 7.10 17,750 62,125
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6,250 6,250 9.30 58,125 58,125
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -6,251 12,500 -33.34
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -1,875 0 -100.00
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -2,500 10,000 -20.00
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100 0 -100.00 95.00 -9,500
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5,090 100 -98.07 94.40 -480,514 9,440
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,936 5,190 -36.13 93.42 -274,273 484,836
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,900 8,126 -18.95 92.33 -175,420 750,244
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -600 10,026 -5.65 91.47 -54,880 917,045
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2,500 10,626 30.77 7.10 17,750 75,445
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6,251 8,126 333.39 9.30 58,134 75,572
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 1,875 1,875 9.14 17,138 17,138
2014-12-16 2014-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance-Based Stock Option (Right to Buy)
A - Award 10,834 10,834
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -6,250 18,751 -25.00
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -1,875 1,875 -50.00
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -2,500 12,500 -16.67
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -800 0 -100.00 73.03 -58,422
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6,625 800 -89.23 72.27 -478,766 57,813
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,200 7,425 -30.12 71.34 -228,275 529,669
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2,500 10,625 30.77 7.10 17,750 75,438
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6,250 8,125 333.33 9.30 58,125 75,562
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 1,875 1,875 9.14 17,138 17,138
2014-06-19 2014-06-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -6,250 25,001 -20.00
2014-06-19 2014-06-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -1,875 3,750 -33.33
2014-06-19 2014-06-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -2,500 15,000 -14.29
2014-06-19 2014-06-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8,127 0 -100.00 69.97 -568,620
2014-06-19 2014-06-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,498 8,127 -23.51 69.33 -173,178 563,418
2014-06-19 2014-06-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6,250 10,625 142.86 9.30 58,125 98,812
2014-06-19 2014-06-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2,500 4,375 133.33 7.10 17,750 31,062
2014-06-19 2014-06-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 1,875 1,875 9.14 17,138 17,138
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -22,145 0 -100.00
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -6,249 31,251 -16.66
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -1,875 5,625 -25.00
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -2,500 17,500 -12.50
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,944 0 -100.00 75.15 -146,094
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -22,044 1,944 -91.90 74.08 -1,633,110 144,019
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8,781 23,988 -26.80 73.34 -644,020 1,759,337
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2,500 32,769 8.26 7.10 17,750 232,660
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6,249 30,269 26.02 9.30 58,116 281,502
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 1,875 24,020 8.47 9.14 17,138 219,543
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 22,145 22,145 12.96 286,999 286,999
2014-02-25 2014-02-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
I - Other -2,615 0 -100.00 90.10 -235,612
2014-01-27 2014-01-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -700 0 -100.00 87.44 -61,208
2014-01-27 2014-01-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,100 700 -61.11 86.60 -95,260 60,620
2014-01-27 2014-01-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,221 1,800 -70.10 85.77 -362,056 154,395
2014-01-27 2014-01-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,869 6,021 -23.69 84.57 -158,065 509,207
2014-01-27 2014-01-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -4,698 7,890 -37.32 89.49 -420,424 706,076
2013-12-18 2013-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 32,500 32,500
2013-12-18 2013-12-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -18,480 22,145 -45.49
2013-12-18 2013-12-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9,980 12,588 -44.22 61.40 -612,762 772,891
2013-12-18 2013-12-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8,500 22,568 -27.36 60.59 -514,999 1,367,352
2013-12-18 2013-12-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 18,480 31,068 146.81 12.96 239,501 402,641
2013-12-18 2013-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -6,250 37,500 -14.29
2013-12-18 2013-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -3,750 7,500 -33.33
2013-12-18 2013-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -5,000 20,000 -20.00
2013-12-18 2013-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,256 12,588 -25.27 60.78 -258,669 765,068
2013-12-18 2013-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -10,744 16,844 -38.94 60.19 -646,629 1,013,758
2013-12-18 2013-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5,000 27,588 22.14 7.10 35,500 195,875
2013-12-18 2013-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6,250 22,588 38.25 9.30 58,125 210,068
2013-12-18 2013-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3,750 16,338 29.79 9.14 34,275 149,329
2013-09-12 2013-09-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -6,250 43,750 -12.50
2013-09-12 2013-09-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -700 12,588 -5.27 58.18 -40,724 732,333
2013-09-12 2013-09-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5,550 13,288 -29.46 57.39 -318,514 762,598
2013-09-12 2013-09-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6,250 18,838 49.65 9.30 58,125 175,193
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -6,250 50,000 -11.11
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -3,750 11,250 -25.00
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -5,000 25,000 -16.67
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100 12,588 -0.79 31.75 -3,175 399,669
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,900 12,688 -27.86 31.07 -152,249 394,233
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5,000 17,588 39.72 7.10 35,500 124,875
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6,250 12,588 -33.18 31.07 -194,196 391,126
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6,250 18,838 49.65 9.30 58,125 175,193
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,750 12,588 -22.95 31.07 -116,517 391,126
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3,750 16,338 29.79 9.14 34,275 149,329
2013-03-11 2013-03-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -6,250 56,250 -10.00
2013-03-11 2013-03-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6,250 12,588 -33.18 24.55 -153,415 308,990
2013-03-11 2013-03-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6,250 18,838 49.65 9.30 58,125 175,193
2012-12-21 2012-12-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 50,000 50,000
2012-12-12 2012-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -3,750 15,000 -20.00
2012-12-12 2012-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -6,250 62,500 -9.09
2012-12-12 2012-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -10,000 12,588 -44.27 19.00 -190,000 239,172
2012-12-12 2012-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3,750 22,588 19.91 9.14 34,275 206,454
2012-12-12 2012-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6,250 18,838 49.65 9.30 58,125 175,193
2012-12-12 2012-12-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -4,777 30,000 -13.74
2012-12-12 2012-12-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,777 12,588 -27.51 17.00 -81,209 213,996
2012-12-12 2012-12-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 4,777 17,365 37.95 7.10 33,917 123,292
2012-12-06 2012-12-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -2,400 34,777 -6.46
2012-12-06 2012-12-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,400 12,588 -16.01 17.04 -40,896 214,500
2012-12-06 2012-12-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2,400 14,988 19.07 7.10 17,040 106,415
2012-12-04 2012-11-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -2,823 37,177 -7.06
2012-12-04 2012-11-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,823 12,588 -18.32 17.03 -48,072 214,359
2012-12-04 2012-11-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2,823 15,411 22.43 7.10 20,043 109,418
2012-09-12 2012-09-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -4,916 68,750 -6.67
2012-09-12 2012-09-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,916 12,588 -28.09 19.00 -93,404 239,172
2012-09-12 2012-09-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 4,916 17,504 39.05 9.30 45,719 162,787
2012-09-12 2012-09-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -1,334 73,666 -1.78
2012-09-12 2012-09-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,334 12,588 -9.58 19.00 -25,346 239,172
2012-09-12 2012-09-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 1,334 13,922 10.60 9.30 12,406 129,475
2012-07-18 2012-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -25,000 75,000 -25.00
2012-07-18 2012-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -11,250 18,750 -37.50
2012-07-18 2012-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -11,250 12,588 -47.19 19.00 -213,750 239,172
2012-07-18 2012-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 11,250 23,838 89.37 9.14 102,825 217,879
2012-07-18 2012-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -25,000 12,588 -66.51 19.00 -475,000 239,172
2012-07-18 2012-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 25,000 37,588 198.60 9.30 232,500 349,568
2012-01-25 2012-01-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 12,588 12,588
2009-03-13 3 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
799
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)